pups did display an increased circulating cytokine response to the cecal slurry compared with wild type, with increased expression of IL-6, IL-10, and TNF-a levels. Within the peritoneal cavity, sepsis induced an influx of neutrophils, a finding that was increased in PD-1 -/-pups. Although the T-cell response was unaffected by PD-1, it was noted that cecal slurry induced a loss of peritoneal B cells in WT, while the peritoneal B-cell population was preserved in PD-1 -/-pups. Conclusion. Our data suggest that the checkpoint protein, PD-1, plays an important role in controlling the immune response to sepsis in the neonate, ultimately affecting sepsis-related mortality in this neonatal murine model of sepsis. Akin to adult studies, these data further emphasize the potential therapeutic target for PD-1 across a spectrum of septic patients. (Surgery 2017; 161:1387-93.) From the Division of Surgical Research, Department of Surgery, a Brown University, Rhode Island Hospital, Providence, RI; and the Laboratory of Inflammation Biology and Surgical Science, Departments of Surgery, Anesthesia, Aging, and Geriatric Research, and Molecular Genetics and Microbiology, b University of Florida College of Medicine, Gainesville, FL SEPSIS CONTINUES to be a major contributor to morbidity and mortality in neonates worldwide. Indeed improving survival in children under 5 is one of the targets of the United Nations' Millennium Development Goals. 1 Nearly three-quarters of all neonatal deaths are related to sepsis, with an estimated worldwide 4 million deaths annually in the first 7 days of life. Despite advances in the operative and intensive care unit care of neonates with sepsis, there remains a dearth of knowledge regarding the underlying mechanistic interactions between the bacterial burden and the neonatal immune system. Healthy neonates, even without an infectious insult, are noted to display a degree of underdevelopment of the immune system as well as immune dysfunction. These findings include an underdeveloped lymphocytic response, a relative inability of normal neutrophils and monocytes to migrate to a site of injury or infection, as well as a reduced ability of neutrophils to develop neutrophil extracellular traps (NETs). 2 After an injury or an infection, akin to their adult counterparts, it is also evident that immune exhaustion and dysfunction occurs in neonates. 3 Specifically, among both septic patients and adult murine models, sepsis-induced immune dysfunction involves alterations in costimulatory/coinhibitory receptors and the checkpoint protein, programmed cell death receptor-1 (PD-1). [4] [5] [6] [7] [8] PD-1 has emerged as a key regulator of immune function in a broad spectrum of illnesses from cancer 9 to sepsis. 5 PD-1, a member of the B7-CD28 superfamily, functions as a coinhibitory/costimulatory receptor. We have shown a role for PD-1 in adult sepsis in both murine models and critically ill patients. 6, 10 Furthermore, the PD-1:PD-L1 pathway regulates the balance between a strong immune response with effective microbial clearance versus an overexuberant response and end-organ damage, 4 a major contributor to sepsis-related morbidity and mortality.
Information that is available regarding the control of neonatal sepsis appears to denote that mechanisms similar to those seen in adult sepsis may be affecting control and outcomes of neonatal sepsis. 11 Given the clear and evident role of PD-1 in adult sepsis, we undertook an investigation of the role of PD-1 in modulating the neonatal response to peritoneal sepsis.
MATERIALS AND METHODS
Mice. Wild-type (WT) mouse pups were bred from C57BL/6J parents. C57BL/6 mice deficient in PD-1 (PD-1 -/-) were used to breed the knockout strains (kindly provided by Tasuku Honjo, Kyoto University, Kyoto, Japan, via Megan Sykes at the Massachusetts General Hospital, Charlestown, MA). Both WT and PD-1 -/-were developmentally normal with normal growth rates and weaning patterns. All mice were bred at Rhode Island Hospital and maintained at our institution's rodent facility receiving standard care, and dams received standard chow.
All pups used were aged 5-7 days old at the start of any experimental procedure. Cecal slurry model. The cecal slurry (CS) model at our institution is modified on the model previously described by Wynn et al. 12 In brief, a na€ ıve, WT, adult donor mouse (C57BL/6J) was killed and cecal contents were harvested. These cecal contents were mixed with 5% dextrose solution to create a CS with a concentration of 80 mg/mL. Pups from each litter used were randomly assigned to na€ ıve (N), sham (Sh), or cecal slurry (CS) groups. These were repeated across 4-5 litters.
For the CS group, pups aged 5-7 days old underwent intraperitoneal (IP) injection of cecal slurry at an LD 70 (1.3 mg/g body weight) as a septic challenge. 12 Matched pups from the same litter underwent IP injection of 0.9% saline, which served as the Sh control. Selected pups from the same litter that were also brought down to the procedure room but were not separated from the mother and underwent no intervention served as N controls. During all experiments, animals were closely watched and were killed if signs of distress were observed, such as scattering or absence of milk in the neonate, or if they were noted to be moribund.
Survival study. Survival studies were undertaken comparing survival of the pups up to 7 days from the N, Sh, or CS. Survival checks were undertaken every 6 hours for the first 2 days, and then twice daily up to 7 days.
Peritoneal culture analysis. Peritoneal fluid was lavaged and collected using a sterile technique. Blood was collected following decapitation and collected with sterile technique. Blood and fluid were then aliquoted and plated onto blood agar plates and incubated at 408C for 48 hours. Colony forming units (CFUs) were counted. Data are expressed as Log 10 CFU/100mL peritoneal fluid. 4 Circulating cytokines. Circulating cytokine analysis was undertaken using the Cytokine Bead Array (BD Mouse Inflammation Kit Catalogue #552364; BD Biosciences, San Jose, CA), which was prepared per the manufacturer's protocol and analyzed with BD FACSArray (BD Biosciences, San Jose, CA). 4 Given the very small circulating blood volume of the murine pups, we chose selected cytokines, specifically IL-6 as a proinflammatory and IL-10 as an anti-inflammatory marker, as well as TNF-a.
Flow cytometry. Peritoneal cells were collected by lavage, centrifuged and analyzed fresh by flow cytometry as previously described by our laboratory. 4 Cell counts also were undertaken to calculate absolute numbers of cells within each population. Cell populations were identified by forward and side scatter and subsequently gated using monoclonal antibodies along with appropriate isotype controls according to both the manufacturer's recommendation and our prior publications.
The following mono-clonal antibodies conjugated to fluorochromes were used: PE-labeled anti-CD3e (clone 145-2C11; T cells), APC-labeled anti-Gr1 (clone RB6-8C5; neutrophils), and FITClabeled anti-CD45R (B220; clone RA3-6B2; B cells) from eBioscience (San Diego, CA). A BD FACS Aria III was used to assess fluorescence. Data were analyzed with FlowJo (version 9.3.2; Ashland, OR).
Statistical analysis. SigmaPlot 12.5 (Systat Software, San Jose, CA) was used for all analysis. Data are expressed as mean and standard error of the mean. Categorical data were assessed using the v 2 or Fisher exact test. One-way analysis of variance (ANOVA) with Holm-Sidak or the Dunn post hoc analysis was used for continuous data across multiple groups. Survival curves were created using Kaplan-Meier curves.
RESULTS
Survival study. Akin to previous observations, 12 in the WT animals, no mortality was noted in either the na€ ıve pups or pups undergoing Sh peritoneal injection. IP CS injection induced an early mortality of 60% at 48 hours (Fig 1, A) . Similar to WT pups, PD-1 -/-pups undergoing Sh sustained no mortality. However, after cecal slurry, PD-1 -/-pups compared with WT demonstrated markedly improved survival with only 20% vs 60% mortality (P < .05). Furthermore, when PD-1 -/-pups did die, the mortality occurred later in the time course compared with WT pups. (Fig 1, A and B) . Bacterial burden. The improved survival noted in the PD-1 -/-pups was not associated with any change in the peritoneal bacterial burden at 24 hours. In the WT pups, CS when compared with Sh injection, was noted to create a large peritoneal bacterial burden at 24 hours (0 vs 5.9 3 10 6 CFU/microliter; P < .001). This was not associated with the development of a bacteremia response. Likewise, in PD-1 -/-pups, the Sh procedure did not induce any significant bacterial burden, whereas CS did induce a marked peritoneal bacterial burden at 24 hours. This bacterial burden in the survivors at 24 hours after CS was not different between WT or PD-1 -/-pups (5.9 3 10 6 vs 3.8 3 10
6 CFU/microliter; P = not significant; Fig 2) . Circulating cytokines. As expected, 24 hours after CS compared with Sh, an increased concentration of both IL-6 and IL-10 was noted in circulation in WT pups. However, in the PD-1 -/-pups, this finding was even more marked. After CS, the elevation of IL-6 and IL-10 was markedly increased in PD-1 -/-pups when compared with CS in WT pups. In the WT pups, there was no difference in circulating TNF-a expression at 24 hours after CS. However, CS in PD-1 -/-pups induced a significant increase of circulating TNF-a (Fig 3, A, B, and C) .
Peritoneal cavity cell populations. There was no difference in the neutrophil populations after Sh between WT and PD-1 -/-pups. While sepsis, compared with Sh, induced an influx of neutrophils into the peritoneal cavity in WT pups, it was noted that in PD-1 -/-pups, CS was associated with a significantly greater neutrophil influx when compared with that seen in WT pups. As has been observed in adult mice, sepsis (CS) in WT pups induced a marked loss of T lymphocytes in the peritoneal cavity.
This finding was also observed in PD-1 -/-pups after CS with no difference in T-cell populations after CS between WT and PD-1 -/-pups. Conversely, although there was a marked decline in the peritoneal B-cell population after sepsis in the WT pups, it was noted that these B-cell populations were preserved in PD-1 -/-pups (Fig 4, A, B , and C).
DISCUSSION
The immune dysfunction induced by sepsis is a major contributor to mortality and, among survivors, long-term morbidity. This is especially true at the extremes of age. Our lab has a long-standing interest in understanding the perturbations in the immune system within both a murine model as well with critically ill septic patients. 7, 13 We have previously noted a key role for coinhibitory, checkpoint molecules and the alterations in expression of these receptors and ligands, specifically programmed death receptor-1 (PD-1). 5, 6, 10, [14] [15] [16] PD-1 is a checkpoint protein that exists on a wide variety of immune cells. Among its recognized roles, PD-1:PD-L1 is a major, negative costimulatory pathway that regulates and maintains peripheral tolerance. 17 It has been postulated that the PD-1:PD-L1 pathway developed to blunt immune responses in conditions such as infections, allergies, ischemia/injury, and autoimmunity to prevent the tissue destruction and end-organ damage associated with an overexuberant immune response. 18, 19 Within adults, PD-1 is also noted to negatively modulate the immune response to sepsis. 4, 18 With respect to the neonate, the role of PD-1 in neonatal sepsis may be left over from the immunosuppressive functions of the PD-1:PD-L1 pathway in the developing fetus. PD-1 is involved in the earliest stages of immune development, contributing toward the tolerance of the allogenic fetus at the feto-maternal interface. 20 PD-L1 is expressed by fetal tissue and is known to interact with PD-1-expressing maternal cells. Without the immunosuppressive effect of PD-1, fetal loss occurs through a robust maternal immune response. 20, 21 Thus, the neonate is born with a negative inhibitory mechanism aimed at preventing an overexuberant response to the myriad of environmental allergens, including bacterial exposures.
We identified a survival benefit for neonatal pups lacking PD-1 after an abdominal septic challenge. This current finding is in keeping with prior observations in adult mice following cecal ligation and puncture sepsis, wherein adult PD-1 -/-mice displayed improved survival. 10 However, within the neonate, this survival advantage appears to be independent of the ability to clear the peritoneal bacterial burden by 24 hours.
After CS, there was no difference in the peritoneal bacterial burden between WT and PD-1 -/-neonatal pups. This differs from adult murine data demonstrating that PD-1 -/-mice display greater bactericidal activity. 4 A single time point does not fully address the dynamics of how the underdeveloped neonatal immune system handles a bacterial burden. Given the difference seen in mortality by 24 hours, however, the lack of difference in bacterial clearance by this time point would imply that mechanisms other than merely bacterial clearance are involved in the survival benefit seen in PD-1 -/-pups. In keeping with the concept that PD-1 acts in a suppressive fashion, we noted that PD-1 -/-pups displayed a markedly elevated cytokine response. The neonate has emerged from an intrauterine environment aimed specifically against developing proinflammatory responses. [22] [23] [24] The cytokine milieu of the neonate is considerably different from adults, 25 and is largely under the control of negative signaling to prevent an overexuberant response to commensal or environmental organisms. 22, 24 Roger et al 22 noted that releasing the immune system from these immunosuppressive pathways improved both cytokine responses and cellular responses to bacteria. We contend that our cytokine findings are in keeping with these observations. -/-pups. N = 6-9 per group. # P < .05 comparing CS in PD-1 -/-pups to all other groups. *P < .05; ANOVA.
Removing the immunosuppressive effect of PD-1 (PD-1 -/-pups), thereby allowing for a more robust immune response, may be critical for neonatal survival from sepsis. A more comprehensive assessment of the dynamics of cytokine fluxes, with associated downstream pathway alterations, will be critical to understanding timing of any intervention aimed at altering the cytokine response in the immunosuppressed neonate.
We have previously demonstrated a key role for PD-1 in modulating the influx of immune cells into the peritoneal cavity in response to sepsis. 14 We, therefore, reviewed the effect of PD-1 upon neonatal peritoneal immune cellular response to sepsis. Neutrophils from neonates display decreased ability to traffic to a source of infection, decreased NET formation, and decreased ability to clear bacteria after sepsis. 2 We noted that neutrophils did enter the peritoneal cavity in response to sepsis in WT pups. When the negative regulation of PD-1 was lacking (PD-1 -/-pups), however, the neutrophil influx was noted to be more pronounced.
This response is in keeping with other observations in noninfectious acute models, 26 noting that PD-1 -/-mice have a more pronounced neutrophil influx into areas of injury. This suppressive role for PD-1 is thought to limit further tissue destruction. Although our findings support the concept that PD-1 appears to alter neutrophil trafficking, once arrived at the source of infection, namely the peritoneal cavity, PD-1 may not play a role in other neutrophil functioning, such as bacterial clearance.
We noted a divergent effect of PD-1 upon the Tcell versus B-cell peritoneal populations. We think that this may be a reflection of the differentially developed lymphocytic populations in the neonate, 27 as well as potential differences in the role of PD-1 in affecting neonatal T-versus B-cell responses. Within adult populations, PD-1 is noted to be expressed at low levels on na€ ıve T cells, but after activation of these T lymphocytes, PD-1 expression is rapidly upregulated on T lymphocytes. 28 Overexpression of PD-1 has been denoted as a marker of cellular exhaustion. 29 Akin to our adult observations, sepsis induced a marked loss of CD3 + T lymphocytes in the WT pups. Unlike adult observations, 30, 31 however, PD-1 in the neonatal pups did not appear to play a role in the peritoneal T lymphocyte response to sepsis. PD-1 -/-pups still displayed a profound loss of peritoneal CD3
+ lymphocytes similar to their WT counterparts.
The peritoneal B-cell response, however, was affected by PD-1. In WT pups, sepsis induced a loss of B cells, but this finding was reversed in PD-1 -/-pups. Sepsis did not induce a loss of peritoneal B cells in PD-1 -/-pups. Although both neonatal T and B cells display a degree of developmental immaturity, our findings may reflect differences in the mechanistic pathways by which neonatal T versus B cells signal.
Neonatal B-cell responses to antigen are affected by the relatively high expression of negative regulators of B-cell receptor signaling or crosslinking of antigen. This has been strongly linked to CD40 and CD22 expression, 32 regulatory molecules that prevent overactivation of the immune system. Neonatal T-cell signaling dysfunction, however, appears more to be related to alterations in downstream signaling in response to strong antigenic responses 33 rather than the contribution from surface costimulatory signaling.
In conclusion, advances in the care of the septic neonatal patient will only come about through a better understanding of the pathways of sepsis. Although differences exist between neonatal and adult responses to sepsis, the role of PD-1 appears to be consistent across the age spectrum. Further work will be required to focus on the mechanistic steps involved in the PD-1-mediated immune alterations. However, we have demonstrated a key role for the checkpoint protein PD-1 in regulating both the immune response to and ultimately mortality from neonatal sepsis.
